<DOC>
	<DOCNO>NCT02054260</DOCNO>
	<brief_summary>The aim study assess effect Surgicel® ( Fibrillar ) prevent delay bleed endoscopic hemostasis non-variceal upper gastrointestinal bleeding</brief_summary>
	<brief_title>Surgicel® ( Fibrillar ) Non-variceal UGI Bleeding</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<criteria>Patients non variceal upper gastrointestinal bleed proven esophagogastroduodenoscopy Patients active bleeding ( Forrest classification Ia Ib IIa ) Patients upper gastrointestinal tract malignancy Patients acute severe illness Coagulopathy : liver cirrhosis , thrombocytopenia Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>